Well.....there's no doubt that the delays that have plagued mesoblast for the past 12 months have provided opportunities for our competitors to establish their market share of the covid cash. Although it's a good thing for more proven treatments to emerge to tackle this insidious virus......I'm so sick of lockdowns that I really don't care now who beats us to the task....however, reading these articles gives one a 'knot in the guts,' when as SH we know what we have, with the data to support it and here we are still jumping through a tunnel of bureaucratic hoops.
New COVID-19 treatment showing early success in Sydney hospitals
Well.....there's no doubt that the delays that have plagued...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.864M | 3.620M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 74056 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 99486 | 10 |
View Market Depth
| Last trade - 12.33pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |